Literature DB >> 10596280

[Diagnosis and therapy of Lyme neuroborreliosis].

H W Pfister1.   

Abstract

Lyme-Borreliosis which in Europe is transmitted by Ixodes ricinus presents in three stages with 1st a localised infection (erythema chronicum migrans), 2nd a disseminated infection (e.g., meningoradiculitis), and 3rd a persistent chronic infection (e.g., encephalomyelitis, cerebral vasculitis), whereby not all stages invariably become clinically apparent. The diagnosis is based on the typical clinical presentation, the lumbar puncture (lymphocytic pleocytosis), and serological test from the blood as well as from the CSF (intrathecal antibody production!). The frequency of positive serological results depends on the duration and the type of the disease. In stage 1 20-50% of the patients show increased IgM-antibodies, in stage 2 70-90% show increased IgM- and or IgG-antibodies, and in stage 3 almost 100% of the patients have positive IgG-antibodies. The Lyme-Neuroborreliosis usually is treated with Ceftriaxon 2 g/d intravenously over 14 (Stage 2) or 21 (Stage 3) days.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10596280     DOI: 10.1024/0040-5930.56.11.664

Source DB:  PubMed          Journal:  Ther Umsch        ISSN: 0040-5930


  1 in total

1.  Isolated trochlear palsy secondary to Lyme neuroborreliosis.

Authors:  Simon R Bababeygy; Peter A Quiros
Journal:  Int Ophthalmol       Date:  2011-12-20       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.